|
P2-181 O-T03C-0858
Biomaterials for theranostics
-
Drug delivery
Evaluating the Impact of Copper Metal Framework Nanoparticles in Macrophage Polarization to Regulate Inflammation after Myocardial Infarction
Maria Lobita
|
|
P2-182 E-T03C-1369
Biomaterials for theranostics
-
Drug delivery
The development of an injectable drug delivery system to achieve controlled exposure of neurons to neurotrophic growth factors
Svenja Meissner
|
|
P2-183 P-T03C-2704
Biomaterials for theranostics
-
Drug delivery
Targeting drug delivery and efficient lysosomal escape for chemo-photodynamic cancer therapy by a peptide/DNA nanocomplex
Qiusheng Wang
|
|
P2-184 E-T03C-1083
Biomaterials for theranostics
-
Drug delivery
Copper(II) bis(diethyldithiocarbamate) loaded nanomedicine induces cuproptosis against cisplatin-resistant
Yao Lu
|
|
P2-185 P-T03C-2932
Biomaterials for theranostics
-
Drug delivery
Glutamic-Pluronic F127 functionalized zinc oxide nanoparticles for the delivery of anticancer dugs
Ngoc Son Nguyen
|
|
P2-186 O-T03C-0250
Biomaterials for theranostics
-
Drug delivery
Remodeling of imbalanced extracellular matrix homeostasis for reversal of pancreatic fibrosis
Han Han
|
|
P2-187 E-T03C-0140
Biomaterials for theranostics
-
Drug delivery
Pathological barriers normalization strategy for liver fibrosis therapy
Ling-Feng Zhang
|
|
P2-188 O-T03C-0668
Biomaterials for theranostics
-
Drug delivery
Decellularized liver matrix-based nanomedicine for liver regeneration
Yong Heng Lin
|
|
P2-189 P-T03C-2772
Biomaterials for theranostics
-
Drug delivery
2D and 3D in vitro study of novel Pt(IV)-carbohydrate derivatives as targeted anticancer agents against osteosarcoma
Arianna Rossi
|
|
P2-190 O-T03C-0839
Biomaterials for theranostics
-
Drug delivery
Macrophages-based drug delivery for liver disease and use of fluorescent microparticles for cell tracking
Anastasiia Sapach
|
|
P2-191 P-T03C-3495
Biomaterials for theranostics
-
Drug delivery
Targeting liposomal resveratrol to neuronal cells in an in-vitro model of blood-brain-barrier-like Caco-2 cellular monolayer
MEI WEN TSENG
|
|
P2-192 E-T03C-2660
Biomaterials for theranostics
-
Drug delivery
The impact of nanoparticle shape on parenchymal penetration following intrathecal administration
Kha Uyen Dam
|
|
P2-193 E-T03C-0698
Biomaterials for theranostics
-
Drug delivery
An injectable hyaluronan-based hydrogel for the controlled release of antibodies
Daniela Isaacs-Bernal
|
|
P2-194 P-T03C-1871
Biomaterials for theranostics
-
Drug delivery
Effect of anti-aging prodrugs that increase intracellular ATP on C. elegans lifespan
Michiharu Kawahara
|
|
P2-195 E-T03C-3806
Biomaterials for theranostics
-
Drug delivery
Subcutaneously Injectable, Biodegradable In Situ Gelling System for Sustained Release of Insulin to Lower Glucose Level in Diabetic Rats
Hannah Lowe
|
|
P2-196 P-T03C-2492
Biomaterials for theranostics
-
Drug delivery
Development of synthetic ligands targeting bacteria surface
Keita Masuda
|
|
P2-197 O-T03C-0454
Biomaterials for theranostics
-
Drug delivery
Localized delivery of therapeutic proteins to the central nervous system using thermo-responsive hydrogels
Timothy Hughes
|
|
P2-198 E-T03C-2305
Biomaterials for theranostics
-
Drug delivery
PEG-based hydrogel with hyaluronic acid-dexamethasone improves motor and cognitive function in a rat moderate controlled cortical impact TBI model
Ken Webb
|
|
P2-200 P-T03C-1632
Biomaterials for theranostics
-
Drug delivery
Stability of Celecoxib in in vitro release media for drug delivery testing
Thomas Eickner
|
|
P2-201 O-T03C-1261
Biomaterials for theranostics
-
Drug delivery
An Ultra-Swelling Microneedle Device for Facile and Efficient Drug Loading and Transdermal Delivery
Hao Chang
|
|
P2-202 P-T03C-3483
Biomaterials for theranostics
-
Drug delivery
Hybrid Nanocarriers based on Liposome-coated Mesoporous Silica Nanoparticles for Efficient Drug Delivery in Cancer Treatment
Tien Dung Nguyen Dinh
|
|
P2-203 E-T03C-3469
Biomaterials for theranostics
-
Drug delivery
Enhancing Liposome Stability and Targeted Drug Delivery Through Biocompatible Polymer Modification of Soy Lecithin-based iposome
Ngọc Thuy Trang Le
|
|
P2-204 P-T03C-3242
Biomaterials for theranostics
-
Drug delivery
Cathepsin-B-Sensitive Nanocarriers Selectively Deliver Antibodies inside Target Cancer Cells
Horacio Cabral
|
|
P2-205 P-T03C-1922
Biomaterials for theranostics
-
Drug delivery
Multidrug delivery system based on graphene oxide nanoplatforms as an antitumoral strategy
Silvia Panseri
|
|
P2-207 P-T03C-1958
Biomaterials for theranostics
-
Drug delivery
Preparation and Characterization of neuroprotective factor A-loaded Lactic-co-glycolic acid micelle
Ming Hui Yang
|
|
P2-208 E-T03C-2801
Biomaterials for theranostics
-
Drug delivery
Enhancing Breast Cancer (MCF7) Apoptosis: Synergistic Effects of Albumin-targeted Liposomes and Ultrasound for ROS Induction and Tumor Therapy
Ghaleb Husseini
|
|
P2-209 E-T03C-2795
Biomaterials for theranostics
-
Drug delivery
Targeted delivery of liposomal curcumin through ultrasound facilitation to a breast cancer cell line
Ghaleb Husseini
|
|
P2-210 E-T03C-3811
Biomaterials for theranostics
-
Drug delivery
Emul-gel formulation for colon-targeted delivery of synbiotics
Shristhi Rawat
|
|
P2-211 E-T03C-0844
Biomaterials for theranostics
-
Drug delivery
Drug delivery by degradation of dense hydroxyapatite-based composites
Aliya Sharipova
|
|
P2-212 O-T03C-0843
Biomaterials for theranostics
-
Drug delivery
Inducing microscale discretisation to impart sprayability to an inherently antifibrotic biopolysaccharide to inhibit mucosal scarring in epidermolysis bullosa
Thomas Robinson
|
Login
